MICOSPECTONE

Description

Active Ingredient: Lincomycin – spectinomycin

KEY POINTS

Two active substances with synergic action
Wide distribution and penetration into tissues
Excellent local and general tolerance even in newborn animals

COMPOSITION

1 ml contains: lincomycin hydrochloride 56.7 mg equivalent to lincomycin 50 mg, spectinomycin hydrochloride 150 mg equivalent to spectinomycin 100 mg.

PHARMACEUTICAL FORM

Injectable solution.

TARGET SPECIES

Cattle, sheep, goats

PROPERTIES

Micospectone is an association of lincomycin and spectinomycin in 1:2 ratio.
Lincomycin is a lincosamide antibiotic with a spectrum of action mainly against Gram-positive bacteria and mycoplasmas. It exhibits a very high degree of distribution to all organs and tissues, where concentrations are higher than those observed in the blood.
Spectinomycin is an aminocyclitol antibiotic with a spectrum of action which is slightly broader than that of lincomycin in that it is active against some Gram-positive microorganisms, most Gram-microorganisms and mycoplasmas.
Administered by parenteral route, spectinomycin exhibits a sufficiently high degree of diffusion in the entire organism.
The concomitant use of the two active ingredients determines evident synergic action towards many bacterial pathogens, including mycoplasmas. Minimum inhibitory concentrations are considerably lower than those found for either antibiotic alone.

INDICATIONS

Micospectone is indicated in infections caused by microorganisms sensitive to the lincomycin-spectinomycin association: mammary and uro-genital infections (mastitis, metritis, contagious agalactia, MMA of sows); respiratory infection due to bacteria or mycoplasma; arthritis, polyarthritis, arthrosynovitis and foot infections, septicaemia, bacterial enteritis, bloody scours, exudative epidermitis.